Send feedback

GUCY2D p.Asp412=

c.1236C>T · rs61749678 · VCV98539

Likely benign Expert panel
Classification
Likely benign
ClinVar
Review
Expert panel ★★★☆
ClinVar · 8 submitters
gnomAD v4.1
Rare
rare (popmax 0.129%, nfe)
Conditions
3
GUCY2D-related recessive retinopathy

ClinGen expert panel — Leber Congenital Amaurosis/early onset Retinal Dystrophy VCEP

Likely Benign for GUCY2D-related recessive retinopathy. Applied ACMG criteria (verbatim):

BP7 BP4

Curation rationale (ClinGen, verbatim)

NM_000180.4(GUCY2D):c.1236C>T (p.Asp412=) is a synonymous variant in exon 4 of 20. This variant is present in gnomAD v4.1.0 at a total allele frequency of 0.001028 with 1659 alleles / 1,613,498 total alleles, which is higher than the ClinGen LCA/eoRD VCEP PM2_Supporting threshold of <0.0004 and fails to meet this criterion. This variant has a Grpmax allele frequency of 0.001233, with 1519 alleles / 1180008 total alleles in the European (non-Finnish) population, which is lower than the ClinGen LCA/eoRD VCEP BS1 threshold of >0.0016 and fails to meet this criterion as well. The computational predictor REVEL has no data as this is a synonymous variant. The splicing impact predictor SpliceAI gives a delta score of 0, which is below the ClinGen LCA/eoRD VCEP recommended threshold of <0.1 and does not predict an impact on splicing (BP4, BP7). In summary, this variant meets the criteria to be classified as Likely Benign for GUCY2D-related recessive retinopathy based on the ACMG/AMP criteria applied, as specified by the ClinGen LCA/eoRD VCEP: BP4, BP7. (VCEP specifications version 1.0.0; date of approval 01/22/2025).

ClinGen Evidence Repository → · reported verbatim, not re-tallied by Sugi Variant.

Computational evidence

Protein change
Missense predictors do not apply to this variant type; conservation carries the signal.
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP -0.11GERP -1, phastCons 0.001
Overall
CADD3.037PHRED · no single calibrated threshold — expert panels disagree

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.129% European (non-Finnish) · 1,519/1,180,008 alleles
Filtering AF 0.123% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.121%
Overall 0.103% 1,659/1,613,498 alleles · rare exomes 1,520/1,461,172 · genomes 139/152,326 · joint denominator
Ancestry group Frequency 1 in
European (non-Finnish)grpmax 0.129% 777
Admixed American 0.0966% 1,035
Finnishnot grpmax-eligible 0.0599% 1,670
Remaining individualsnot grpmax-eligible 0.0448% 2,231
Middle Eastern 0.0334% 2,998
African / African-American 0.0147% 6,824
Ashkenazi Jewishnot grpmax-eligible 0.00338% 29,600
South Asian 0.0022% 45,536

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
GUCY2D
Protein
p.Asp412=
Coding
c.1236C>T
MANE Select
NM_000180
dbSNP
rs61749678
Type
single nucleotide variant
Location
chr17:8006572 (GRCh38)
Gene constraint
LOEUF 0.911 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 82.37
Full GUCY2D gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/gucy2d-p-asp412 (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown